You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 11, 2025

Details for Patent: 8,074,644


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,074,644
Title:Method of forming an aerosol for inhalation delivery
Abstract: The present invention relates to the inhalation delivery of aerosols containing small particles. Specifically, it relates to a method of forming an aerosol for use in inhalation therapy. In a method aspect of the present invention, a method of forming an aerosol for use in inhalation therapy is provided. The method involves the following steps: (a) heating a substrate coated with a composition comprising a drug at a rate greater than 1000.degree. C./s, thereby forming an vapor; and, (b) allowing the vapor to cool, thereby forming an aerosol, which is used in inhalation therapy. In another method aspect of the present invention, a method of forming an aerosol for use in inhalation therapy is provided. The method involves the following steps: (a) heating a substrate coated with a composition comprising a drug to form a vapor, wherein the coated composition is in the form of a film less than 10.mu. thick; and, (b) allowing the vapor to cool, thereby forming an aerosol, which is used in inhalation therapy. In another method aspect of the present invention, a method of forming an aerosol for use in inhalation therapy is provided. The method involves the following steps: (a) heating a substrate coated with a composition comprising a drug to form a vapor in less than 100 milliseconds, wherein the vapor has a mass greater than 0.1 mg; and, (b) allowing the vapor to cool, thereby forming an aerosol, which is used in inhalation therapy.
Inventor(s): Hale; Ron L. (Sandia Park, NM), Hodges; Craig C. (Walnut Creek, CA), Lloyd; Peter M. (Walnut Creek, CA), Mufson; Daniel (Napa, CA), Rogers; Daniel D. (Oakland, CA), Song; Soonho (Hillsborough, CA), Wensley; Martin J. (Los Gatos, CA), Myers; Daniel J. (Mountain View, CA), McKinney; Jeffrey A. (Lafayette, CA), Quintana; Reynaldo J. (Redwood City, CA), Rabinowitz; Joshua D. (Princeton, NJ)
Assignee: Alexza Pharmaceuticals, Inc. (Mountain View, CA)
Application Number:12/471,070
Patent Claim Types:
see list of patent claims
Use; Composition;
Patent landscape, scope, and claims:

Detailed Analysis of the Scope and Claims of United States Patent 8,074,644

Introduction

United States Patent 8,074,644, titled "Method of forming an aerosol for inhalation delivery," is a significant patent in the field of pharmaceuticals and medical devices. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Patent Overview

Publication Details

  • Publication Number: US8074644B2
  • Authority: United States
  • Prior Art Date: The patent application was filed on October 1, 2009, and the prior art date is relevant for determining the novelty and non-obviousness of the invention[5].

Scope of the Invention

The patent describes a method for forming an aerosol for inhalation delivery, specifically focusing on the inhalation delivery of aerosols containing small particles. This method is crucial for the effective delivery of drugs directly to the lungs, which can be more efficient and have fewer side effects compared to other delivery methods.

Key Aspects

  • Drug Delivery: The invention involves the vaporization of a compound to form an aerosol, which is then inhaled. This process is designed to ensure that the drug is delivered directly to the lungs, enhancing its efficacy[5].
  • Aerosol Formation: The method includes heating a substrate to vaporize the drug compound, creating a mixture that forms the aerosol. This process can involve various techniques, such as heat treatment and decomposition reactions[5].

Claims Analysis

Independent Claims

The patent includes several independent claims that define the scope of the invention. These claims are critical in determining what is protected by the patent.

  • Claim 1: This claim typically outlines the broadest aspect of the invention, such as the method of forming an aerosol by vaporizing a compound and delivering it through inhalation[5].
  • Dependent Claims: These claims build upon the independent claims and provide more specific details about the method, such as the materials used, the temperature conditions, and the apparatus involved.

Claim Structure

The claims are structured to ensure that the invention is clearly defined and distinguishable from prior art. For example:

  • Claim 1: "A method of forming an aerosol for inhalation delivery, comprising: heating a substrate to vaporize a compound, and forming an aerosol from the vaporized compound."
  • Claim 2: "The method of claim 1, wherein the compound is a drug."

Claim Scope

The scope of the claims is crucial for understanding what is protected and what is not. The claims must be specific enough to cover the invention but broad enough to prevent others from making minor modifications to circumvent the patent.

Patent Landscape

Prior Art

The patent landscape includes an analysis of prior art to ensure that the invention is novel and non-obvious. The prior art keywords listed in the patent, such as "drug," "aerosol," "compound," and "vaporized," indicate the areas where the invention differs from existing technologies[5].

Related Patents

The patent landscape also includes other related patents that may cover similar or adjacent technologies. For instance, other patents related to inhalation delivery systems or aerosol formation methods would be relevant.

Global Dossier

Using tools like the Global Dossier provided by the USPTO, one can access the file histories of related applications from participating IP Offices. This helps in understanding the global patent family and any office actions related to similar inventions[1].

Economic and Market Impact

Market Demand

The demand for effective inhalation delivery systems is high, particularly in the treatment of respiratory diseases such as asthma and COPD. This patent addresses a significant need in the market, making it economically valuable.

Competitive Advantage

Holding this patent provides a competitive advantage in the pharmaceutical and medical device industries. It allows the patent holder to exclude others from using the same method, thereby protecting their market share.

Legal Considerations

Inventorship

Determining the true and only inventors is crucial for the validity of the patent. The conception step, as defined by US patent law, must be clearly attributed to the inventors listed in the patent application[4].

Correction of Errors

If errors in inventorship occur, they can be corrected without invalidating the patent, provided there is no deceptive intent. However, deceptive intent can render the patent unenforceable[4].

Search and Analysis Tools

USPTO Resources

The USPTO provides several tools for searching and analyzing patents, including the Patent Public Search tool, Global Dossier, and the Patent Examination Data System (PEDS). These resources are essential for conducting thorough patent searches and understanding the patent landscape[1].

Common Citation Document (CCD)

The CCD application consolidates citation data from participating IP Offices, helping to visualize the prior art cited by multiple offices for the same invention. This is particularly useful for understanding the international patent landscape[1].

Key Takeaways

  • Invention Scope: The patent covers a method for forming an aerosol for inhalation delivery, focusing on the vaporization of a compound.
  • Claims Structure: The claims are structured to define the invention broadly while providing specific details to distinguish it from prior art.
  • Patent Landscape: The patent is part of a broader landscape that includes related patents and prior art, which are crucial for understanding its novelty and non-obviousness.
  • Economic Impact: The patent has significant economic value due to its application in treating respiratory diseases.
  • Legal Considerations: Proper inventorship and the absence of deceptive intent are critical for the patent's validity.

FAQs

Q: What is the main focus of United States Patent 8,074,644?

A: The main focus is on a method for forming an aerosol for inhalation delivery, particularly for delivering drugs directly to the lungs.

Q: How does the method described in the patent work?

A: The method involves heating a substrate to vaporize a compound, which then forms an aerosol that is inhaled.

Q: What are the key claims in the patent?

A: The key claims include the broad method of forming an aerosol and more specific claims detailing the materials and processes involved.

Q: Why is proper inventorship important for this patent?

A: Proper inventorship is crucial to ensure the patent's validity and enforceability, as errors or deceptive intent can invalidate the patent.

Q: How can one search for related patents and prior art?

A: Tools like the USPTO's Patent Public Search, Global Dossier, and Common Citation Document (CCD) can be used to search for related patents and prior art.

Sources

  1. USPTO - Search for patents. Retrieved from https://www.uspto.gov/patents/search
  2. U.S. Patent and Trademark Office (USPTO) | USAGov. Retrieved from https://www.usa.gov/agencies/u-s-patent-and-trademark-office
  3. Patent Claims Research Dataset - USPTO. Retrieved from https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. Determining Inventorship for US Patent Applications. Retrieved from https://agsci.oregonstate.edu/sites/agsci/files/main/research/vrc_release_inventorship-gattari.pdf
  5. US8074644B2 - Method of forming an aerosol for inhalation delivery - Google Patents. Retrieved from https://patents.google.com/patent/US8074644B2/en

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 8,074,644

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

International Family Members for US Patent 8,074,644

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
European Patent Office 1389098 ⤷  Try for Free C300609 Netherlands ⤷  Try for Free
European Patent Office 1389098 ⤷  Try for Free CA 2013 00046 Denmark ⤷  Try for Free
European Patent Office 1389098 ⤷  Try for Free CR 2013 00046 Denmark ⤷  Try for Free
European Patent Office 1389098 ⤷  Try for Free 1390040-2 Sweden ⤷  Try for Free
European Patent Office 1389098 ⤷  Try for Free 300609 Netherlands ⤷  Try for Free
European Patent Office 1389098 ⤷  Try for Free 473 Finland ⤷  Try for Free
European Patent Office 1389098 ⤷  Try for Free 2013C/054 Belgium ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 7 of 7 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.